Japanese health tech company Omron has officially launched its blood pressure smartwatch HeartGuide at CES in Las Vegas. Omron Complete, a blood pressure monitor with EKG capability, was also unveiled. The devices are part of the company’s mission towards the elimination of cardiac events, appropriately named Going for Zero.
Essential reading: Top smart blood pressure monitors
Much has already been written about the FDA-recognized HeartGuide. This is the world’s first watch-sized sphygmanometer that promises readings as accurate as you would get from upper arm models. Coming up with the device was by no means an easy task. Omron has filed more than 80 new patents to create the thing.
HeartGuide has no cuffs, wires or hoses, and will even alert you to reposition your arm it if needed for improved accuracy. The device can hold up to 100 readings and works in conjunction with its mobile app, HeartAdvisor.
In order to draw correlation between your behavior and heart health, HeartGuide also keeps tabs on steps, distance, calories burned and sleep. The app tracks and graphs all this and spits out actionable insights based on your personalized data.
“There are 103 million hypertensive Americans and, this year, Omron Healthcare will offer a range of devices tailored to serve every one of them,” Omron Healthcare President and CEO Ranndy Kellogg said.
“More than 80% of heart attacks and strokes are preventable with lifestyle changes. It all begins with regular blood pressure monitoring and achieving better insights into your heart health.”
For a true smartwatch experience, you can also use HeartGuide to set personal daily reminders and get notifications when you receive calls, texts or emails on your smartphone. A typical user can expect to charge the device about 2 or 3 times per week, depending on usage of course.
Along with HeartGuide, Omron has also unveiled Complete, its first blood pressure monitor with EKG capability. Similar to the Withings BPM Core, it allows users to store, track and share their blood pressure and EKG readings with their doctor. It will also warn you if it spots signs of atrial fibrillation (AFib).
“Having the ability to measure two important risk factors for stroke in one device provides those living with AFib a simple and more accessible way to keep track of their condition and know when to seek treatment. This kind of control can mean lower risk of stroke and greater peace of mind,” added Kellogg.
You can order Omron HeartGuide now for a hefty $499 for delivery in March. It’s only available in the US at the moment, but other countries to follow soon (depending on regulatory approval). Omron Complete is currently under FDA review and is expected to be available for purchase in the next few months.
Like this article? Subscribe to our monthly newsletter and never miss out!